

Ocular excipients specifically refer to those chemical compounds or materials intentionally included in eye drops or ophthalmic drugs intended for topical administration directly onto the surface of the eye or ocular tissues. Their primary function is to enhance drug delivery effectiveness while maintaining safety, efficacy, stability, and compatibility with other components present in the formulation.
The global Ocular Excipients market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The ocular excipients market has been gaining traction over the past several years due to rising demand for better performing and safer eye drop formulations, coupled with increasing regulatory pressures encouraging manufacturers to develop newer and more sophisticated excipients meeting ever-tightening quality standards.
Currently, the market landscape is characterized by intense competition among multinational players operating across multiple geographies and serving diverse customer segments. There exists a wide variety of ocular excipients available in the market catering to distinct formulation requirements across various eye care applications.
Major drivers fueling the growth of the ocular excipients industry include the burgeoning population requiring vision correction treatments along with aging demographic patterns necessitating geriatric eye care services amplifying corresponding market expansion possibilities leveraging product diversification trends emphasizing personalized therapy options adapting to unique individual biometric characteristics fostering customizable medical approaches delivering optimized healthcare outcomes accommodating divergent consumer preferences harmonizing overall sector evolution.
Nevertheless, factors like pricing pressure from cost-conscious consumers and payers, combined with escalating R&D expenses necessary for developing novel formulation platforms capable of addressing complex biomolecular issues associated with chronic ophthalmologic conditions, pose challenges to industry participants' ability to generate satisfactory financial returns perpetually navigating volatile market environments amidst uncertain economic climates impacting business profitability amidst prevailingly tight fiscal circumstances.
This report aims to provide a comprehensive presentation of the global market for Ocular Excipients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Excipients.
Report Scope
The Ocular Excipients market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ocular Excipients market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ocular Excipients manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Group
BASF
Beneo
Evonik
Lubrizol Corporation
Fuji Chemical Industry
Croda Health Care
Farmigea
JRS Pharma
Pfanstiehl
Perkin Elmer
DFE Pharma
Abitec
Segment by Type
Dilutents
Glidants
Disintegrants
Binders
Lubricants
Tablet Coatings and Films
Colouring Agents
Segment by Application
Pharmaceutical Companies
Contract Manufacturing Organizations (CMOs)
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ocular Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ocular Excipients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Ocular Excipients Market Overview
1.1 Product Overview and Scope of Ocular Excipients
1.2 Ocular Excipients Segment by Type
1.2.1 Global Ocular Excipients Market Value Comparison by Type (2024-2030)
1.2.2 Dilutents
1.2.3 Glidants
1.2.4 Disintegrants
1.2.5 Binders
1.2.6 Lubricants
1.2.7 Tablet Coatings and Films
1.2.8 Colouring Agents
1.3 Ocular Excipients Segment by Application
1.3.1 Global Ocular Excipients Market Value by Application: (2024-2030)
1.3.2 Pharmaceutical Companies
1.3.3 Contract Manufacturing Organizations (CMOs)
1.3.4 Others
1.4 Global Ocular Excipients Market Size Estimates and Forecasts
1.4.1 Global Ocular Excipients Revenue 2019-2030
1.4.2 Global Ocular Excipients Sales 2019-2030
1.4.3 Global Ocular Excipients Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ocular Excipients Market Competition by Manufacturers
2.1 Global Ocular Excipients Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ocular Excipients Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ocular Excipients Average Price by Manufacturers (2019-2024)
2.4 Global Ocular Excipients Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ocular Excipients, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ocular Excipients, Product Type & Application
2.7 Ocular Excipients Market Competitive Situation and Trends
2.7.1 Ocular Excipients Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ocular Excipients Players Market Share by Revenue
2.7.3 Global Ocular Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ocular Excipients Retrospective Market Scenario by Region
3.1 Global Ocular Excipients Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ocular Excipients Global Ocular Excipients Sales by Region: 2019-2030
3.2.1 Global Ocular Excipients Sales by Region: 2019-2024
3.2.2 Global Ocular Excipients Sales by Region: 2025-2030
3.3 Global Ocular Excipients Global Ocular Excipients Revenue by Region: 2019-2030
3.3.1 Global Ocular Excipients Revenue by Region: 2019-2024
3.3.2 Global Ocular Excipients Revenue by Region: 2025-2030
3.4 North America Ocular Excipients Market Facts & Figures by Country
3.4.1 North America Ocular Excipients Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ocular Excipients Sales by Country (2019-2030)
3.4.3 North America Ocular Excipients Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ocular Excipients Market Facts & Figures by Country
3.5.1 Europe Ocular Excipients Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ocular Excipients Sales by Country (2019-2030)
3.5.3 Europe Ocular Excipients Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ocular Excipients Market Facts & Figures by Country
3.6.1 Asia Pacific Ocular Excipients Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ocular Excipients Sales by Country (2019-2030)
3.6.3 Asia Pacific Ocular Excipients Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Ocular Excipients Market Facts & Figures by Country
3.7.1 Latin America Ocular Excipients Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ocular Excipients Sales by Country (2019-2030)
3.7.3 Latin America Ocular Excipients Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ocular Excipients Market Facts & Figures by Country
3.8.1 Middle East and Africa Ocular Excipients Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ocular Excipients Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ocular Excipients Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ocular Excipients Sales by Type (2019-2030)
4.1.1 Global Ocular Excipients Sales by Type (2019-2024)
4.1.2 Global Ocular Excipients Sales by Type (2025-2030)
4.1.3 Global Ocular Excipients Sales Market Share by Type (2019-2030)
4.2 Global Ocular Excipients Revenue by Type (2019-2030)
4.2.1 Global Ocular Excipients Revenue by Type (2019-2024)
4.2.2 Global Ocular Excipients Revenue by Type (2025-2030)
4.2.3 Global Ocular Excipients Revenue Market Share by Type (2019-2030)
4.3 Global Ocular Excipients Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ocular Excipients Sales by Application (2019-2030)
5.1.1 Global Ocular Excipients Sales by Application (2019-2024)
5.1.2 Global Ocular Excipients Sales by Application (2025-2030)
5.1.3 Global Ocular Excipients Sales Market Share by Application (2019-2030)
5.2 Global Ocular Excipients Revenue by Application (2019-2030)
5.2.1 Global Ocular Excipients Revenue by Application (2019-2024)
5.2.2 Global Ocular Excipients Revenue by Application (2025-2030)
5.2.3 Global Ocular Excipients Revenue Market Share by Application (2019-2030)
5.3 Global Ocular Excipients Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck Group
6.1.1 Merck Group Corporation Information
6.1.2 Merck Group Description and Business Overview
6.1.3 Merck Group Ocular Excipients Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Group Ocular Excipients Product Portfolio
6.1.5 Merck Group Recent Developments/Updates
6.2 BASF
6.2.1 BASF Corporation Information
6.2.2 BASF Description and Business Overview
6.2.3 BASF Ocular Excipients Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BASF Ocular Excipients Product Portfolio
6.2.5 BASF Recent Developments/Updates
6.3 Beneo
6.3.1 Beneo Corporation Information
6.3.2 Beneo Description and Business Overview
6.3.3 Beneo Ocular Excipients Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Beneo Ocular Excipients Product Portfolio
6.3.5 Beneo Recent Developments/Updates
6.4 Evonik
6.4.1 Evonik Corporation Information
6.4.2 Evonik Description and Business Overview
6.4.3 Evonik Ocular Excipients Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Evonik Ocular Excipients Product Portfolio
6.4.5 Evonik Recent Developments/Updates
6.5 Lubrizol Corporation
6.5.1 Lubrizol Corporation Corporation Information
6.5.2 Lubrizol Corporation Description and Business Overview
6.5.3 Lubrizol Corporation Ocular Excipients Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lubrizol Corporation Ocular Excipients Product Portfolio
6.5.5 Lubrizol Corporation Recent Developments/Updates
6.6 Fuji Chemical Industry
6.6.1 Fuji Chemical Industry Corporation Information
6.6.2 Fuji Chemical Industry Description and Business Overview
6.6.3 Fuji Chemical Industry Ocular Excipients Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Fuji Chemical Industry Ocular Excipients Product Portfolio
6.6.5 Fuji Chemical Industry Recent Developments/Updates
6.7 Croda Health Care
6.6.1 Croda Health Care Corporation Information
6.6.2 Croda Health Care Description and Business Overview
6.6.3 Croda Health Care Ocular Excipients Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Croda Health Care Ocular Excipients Product Portfolio
6.7.5 Croda Health Care Recent Developments/Updates
6.8 Farmigea
6.8.1 Farmigea Corporation Information
6.8.2 Farmigea Description and Business Overview
6.8.3 Farmigea Ocular Excipients Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Farmigea Ocular Excipients Product Portfolio
6.8.5 Farmigea Recent Developments/Updates
6.9 JRS Pharma
6.9.1 JRS Pharma Corporation Information
6.9.2 JRS Pharma Description and Business Overview
6.9.3 JRS Pharma Ocular Excipients Sales, Revenue and Gross Margin (2019-2024)
6.9.4 JRS Pharma Ocular Excipients Product Portfolio
6.9.5 JRS Pharma Recent Developments/Updates
6.10 Pfanstiehl
6.10.1 Pfanstiehl Corporation Information
6.10.2 Pfanstiehl Description and Business Overview
6.10.3 Pfanstiehl Ocular Excipients Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Pfanstiehl Ocular Excipients Product Portfolio
6.10.5 Pfanstiehl Recent Developments/Updates
6.11 Perkin Elmer
6.11.1 Perkin Elmer Corporation Information
6.11.2 Perkin Elmer Ocular Excipients Description and Business Overview
6.11.3 Perkin Elmer Ocular Excipients Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Perkin Elmer Ocular Excipients Product Portfolio
6.11.5 Perkin Elmer Recent Developments/Updates
6.12 DFE Pharma
6.12.1 DFE Pharma Corporation Information
6.12.2 DFE Pharma Ocular Excipients Description and Business Overview
6.12.3 DFE Pharma Ocular Excipients Sales, Revenue and Gross Margin (2019-2024)
6.12.4 DFE Pharma Ocular Excipients Product Portfolio
6.12.5 DFE Pharma Recent Developments/Updates
6.13 Abitec
6.13.1 Abitec Corporation Information
6.13.2 Abitec Ocular Excipients Description and Business Overview
6.13.3 Abitec Ocular Excipients Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Abitec Ocular Excipients Product Portfolio
6.13.5 Abitec Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ocular Excipients Industry Chain Analysis
7.2 Ocular Excipients Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ocular Excipients Production Mode & Process
7.4 Ocular Excipients Sales and Marketing
7.4.1 Ocular Excipients Sales Channels
7.4.2 Ocular Excipients Distributors
7.5 Ocular Excipients Customers
8 Ocular Excipients Market Dynamics
8.1 Ocular Excipients Industry Trends
8.2 Ocular Excipients Market Drivers
8.3 Ocular Excipients Market Challenges
8.4 Ocular Excipients Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Merck Group
BASF
Beneo
Evonik
Lubrizol Corporation
Fuji Chemical Industry
Croda Health Care
Farmigea
JRS Pharma
Pfanstiehl
Perkin Elmer
DFE Pharma
Abitec
Ìý
Ìý
*If Applicable.